Effects of a Ganoderma lucidum Proteoglycan on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic Islets

Fanzhen Yu,Yilong Teng,Jiaqi Li,Shutong Yang,Zeng Zhang,Yanming He,Hongjie Yang,Chuan-Fan Ding,Ping Zhou
DOI: https://doi.org/10.1021/acsomega.3c02200
IF: 4.1
2023-05-05
ACS Omega
Abstract:Type 2 diabetes (T2D) results from both insulin resistance and pancreatic β-cell dysfunction. A natural proteoglycan extracted from <i>Ganoderma lucidum</i>, namely, <i>FYGL</i>, has been demonstrated to be capable of ameliorating insulin resistance in previous work. In this work, a T2D rat model induced by streptozocin (STZ) and a high-fat diet was used to investigate the effects of <i>FYGL</i> on pancreatic functions, and the transcriptomics of the rat pancreas was used to investigate the biological processes (BP) and signal pathways influenced by <i>FYGL</i> on the gene basis. Furthermore, the results of transcriptomics were verified both by histopathological analyses and protein expression. The studies showed that <i>FYGL</i> positively regulated T2D-related BP and signaling pathways and recovered the pancreatic function, therefore ameliorating hyperglycemia and hyperlipidemia <i>in vivo</i>. Importantly, the recovery of the pancreatic function suggested a crucial strategy to radically treat T2D.
chemistry, multidisciplinary
What problem does this paper attempt to address?